FIELD: chemistry.
SUBSTANCE: invention relates to a diacetate of racemic 18-ethyl-gona-1,3,5(10),8(9)-tetraene-3,17β-diol, having anti-implantation and antioxidant activity with low uterotropic action. Presence of antioxidant activity in said steroid is essential since compounds with such action can be agents for preventing oestrogen-dependent breast cancer.
EFFECT: compounds exhibit anti-implantation and antioxidant activity with low uterotropic action, which is an advantage over agents used in practice.
1 cl, 1 ex, 4 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| RACEMIC 3,17β-DIHYDROXY-7α,18-DIMETHYL-6-OXAEXTRA-1,3,5( 10 ),8(9)-TETRAENE DIACETATE EXHIBITING OSTEOPROTECTIVE, HYPOCHOLESTEREMIC AND ANTIOXIDANT ACTION | 2009 |
|
RU2422455C1 |
| METHYL ETHER OF 16,16-DIMETHYL-2-FLUORO-D-HOMO-8ALPHA-OESTRONE, HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2010 |
|
RU2436792C1 |
| PROCESS FOR PREPARING RACEMIC 8-ISOESTRADIOL | 0 |
|
SU1092158A1 |
| 3-METHOXY-2-FLUORO-18-ETHYL-8α-GONA-1,3,5( 10 )-TRIENES, HAVING OSTEOPROTECTOR AND HYPOCHOLESTEREMIC ACTIVITY | 2009 |
|
RU2418000C1 |
| METHOD FOR INCREASING BODY ADAPTABILITY UNDER THERMAL STRESS | 2013 |
|
RU2553374C1 |
| 14ALPHA,15ALPHA- OR 14BETA,15BETA-METHYLENE DERIVATIVES OF ESTRAN SERIES HAVING INTERCEPTIVE EFFECT | 0 |
|
SU1087525A1 |
| 17,17-DIMETHYL-D-HOMO-B-NOR-8α-OESTRONE HAVING HYPOLIPIDEMIC AND CARDIOPROTECTOR ACTIVITY | 2008 |
|
RU2391351C1 |
| 15β-SUBSTITUTED STEROIDS WITH SELECTIVE OESTROGENIC ACTIVITY | 2005 |
|
RU2386637C2 |
| METHOD OF CORRECTING LIPOPEROXIDATION PROCESSES UNDER ACOUSTIC LOAD UNDER EXPERIMENTAL CONDITIONS | 2023 |
|
RU2806662C1 |
| ANTIPROLIFERATIVE AGENT | 2011 |
|
RU2519727C2 |
